Jove
Visualize
Contact Us

Related Experiment Videos

Statins and proteinuria.

Donald G Vidt1

  • 1Department of Nephrology & Hypertension, Cleveland Clinic Foundation, Desk A51, Cleveland, OH 44195, USA. vidtd@ccf.org

Current Atherosclerosis Reports
|August 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.

The lancet. Diabetes & endocrinology·2015
Same author

Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.

Atherosclerosis·2012
Same author

Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

Clinical therapeutics·2011
Same author

Taking blood pressure: too important to trust to humans?

Cleveland Clinic journal of medicine·2010
Same author

Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Journal of clinical hypertension (Greenwich, Conn.)·2008
Same author

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Current hypertension reports·2008
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, do not cause kidney damage and may improve renal function. Studies show statins can protect kidneys in chronic kidney disease patients.

Area of Science:

  • Nephrology
  • Pharmacology

Background:

  • Proteinuria is sometimes observed with statin use, but it consists of low-molecular weight proteins that resolve upon discontinuation.
  • No evidence of nephrotoxicity or reduced renal function has been linked to approved statin dosages.

Purpose of the Study:

  • To evaluate the impact of statin therapy on renal function, particularly in patients with chronic kidney disease.

Main Methods:

  • Review of clinical studies examining statin effects on proteinuria, creatinine levels, and estimated glomerular filtration rates.
  • Analysis of animal and human studies investigating the renoprotective potential of statins in chronic kidney disease.

Main Results:

  • Statin-associated proteinuria is transient and composed of low-molecular weight proteins.

Related Experiment Videos

  • Clinical studies indicate statins can decrease creatinine and improve estimated glomerular filtration rates.
  • Statin treatment may offer renoprotection in chronic kidney disease beyond standard treatments like blood pressure control and ACE inhibitors.

    • Conclusions:

    • Statins are not nephrotoxic and may improve renal function.
    • Statin therapy shows promise for renoprotection in chronic kidney disease.